May 26, 2016 7:58 PM ET


Company Overview of Aesica Pharmaceuticals Limited

Company Overview

Aesica Pharmaceuticals Limited provides pharmaceutical contract development and manufacturing services. The company offers potency drug substance and drug manufacturing services that include the production of highly potent active pharmaceutical ingredients; formulation development, analytics, and GMP services for pharmaceutical dosage forms that include tablets, capsules, liquids, suspensions, creams, ointments, and inhaled pharmaceuticals; and finished dose manufacturing services, such as wet granulation, tablet production, encapsulation, liquid manufacturing, temperature critical, blister packaging, and bottle packing. It serves pharmaceutical, biotech, and life science companies, as well ...


Quorum Business Park

Benton Lane

Newcastle upon Tyne,  NE12 8BS

United Kingdom

Founded in 2004


44 19 1218 1960


44 19 1266 9447

Key Executives for Aesica Pharmaceuticals Limited

Managing Director
Finance Director
Operations Director
Managing Director of API
Head of Quality - Cramlington Facility
Compensation as of Fiscal Year 2015.

Aesica Pharmaceuticals Limited Key Developments

Aesica Announces Board Appointments

Aesica announced the appointment of two senior business development positions. Detlef Behrens has been appointed to the role of Vice President, Business Development, Finished Dose with Sven Wrabletz joining as Business Development Director, Finished Dose. Detlef has overall responsibility for business development and for finished dose services, covering formulation development, bulk manufacturing and packaging with a full international remit across the Group. Sven is also responsible for finished dose development, manufacturing and packaging but with a geographic remit covering Northern Germany, Benelux and Eastern Europe. Both positions are based in Germany. Detlef reports directly to Ian Muir, Managing Director, Finished Dose and prior to working for Aesica, Detlef held senior BD roles at Piramal and Next Pharma. Sven Wrabletz reports to Detlef Behrens.

Similar Private Companies By Industry

Company Name Region
Abbey Pharma Limited Europe
Absynth Biologics Limited Europe
Acacia Pharma Limited Europe
AccentBio Ltd. Europe
Aclar Limited Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Aesica Pharmaceuticals Limited, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at